Next-generation screen for integrative subtyping and target discovery for KRAS-mutant cancer

被引：0
|
作者：
Yuan, Tina L. [1 ]
Bagni, Rachel [2 ]
Yi, Ming [2 ]
Amzallag, Arnaud [3 ,4 ]
Afghani, Shervin [1 ]
Beam, Katie [2 ]
Burgan, William [2 ]
Fer, Nicole [2 ]
Garvey, Leslie [2 ]
Smith, Brian [2 ]
Waters, Andrew [2 ]
Stephens, Robert [2 ]
Benes, Cyril [3 ,4 ]
McCormick, Frank [1 ]
机构：
[1] UCSF Helen Diller Comprehens Canc Ctr, San Francisco, CA USA
[2] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Canc Res Technol Program, Frederick, MD USA
[3] Massachusetts Gen Hosp, Ctr Canc, Dept Med, Boston, MA USA
[4] Harvard Univ, Sch Med, Boston, MA USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-4690
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4690
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Development of siRNA Payloads to Target KRAS-Mutant Cancer
    Yuan, Tina L.
    Fellmann, Christof
    Lee, Chih-Shia
    Ritchie, Cayde D.
    Thapar, Vishal
    Lee, Liam G.
    Hsu, Dennis J.
    Grace, Danielle
    Carver, Joseph O.
    Zuber, Johannes
    Luo, Ji
    McCormick, Frank
    Lowe, Scott W.
    [J]. CANCER DISCOVERY, 2014, 4 (10) : 1182 - 1197
  • [2] An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer
    Wang, Haiyun
    Lv, Qi
    Xu, Yue
    Cai, Zhaoqing
    Zheng, Jie
    Cheng, Xiaojie
    Dai, Yao
    Janne, Pasi A.
    Ambrogio, Chiara
    Koehler, Jens
    [J]. EBIOMEDICINE, 2019, 49 : 106 - 117
  • [3] PCSK9 IS A THERAPEUTIC TARGET IN KRAS-MUTANT COLORECTAL CANCER
    Wong, Chi Chun
    Wu, Jianlin
    Chan, Lam-Shing
    Ji, Fenfen
    Kang, Wei
    To, Ka Fai
    Sung, Joseph J.
    Yu, Jun
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S64 - S64
  • [4] Closing the door on KRAS-mutant lung cancer
    Cully, Megan
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (11) : 747 - 747
  • [5] Closing the door on KRAS-mutant lung cancer
    Megan Cully
    [J]. Nature Reviews Drug Discovery, 2016, 15 : 747 - 747
  • [6] Current therapy of KRAS-mutant lung cancer
    Ghimessy, Aron
    Radeczky, Peter
    Laszlo, Viktoria
    Hegedus, Balazs
    Renyi-Vamos, Ferenc
    Fillinger, Janos
    Klepetko, Walter
    Lang, Christian
    Dome, Balazs
    Megyesfalvi, Zsolt
    [J]. CANCER AND METASTASIS REVIEWS, 2020, 39 (04) : 1159 - 1177
  • [7] Genetic modifiers of KRAS-mutant colorectal cancer
    Tjader, Nijole P.
    Ramroop, Johnny
    Gandhi, Tanish
    Campbell, Peter T.
    Chan, Andrew T.
    Gallinger, Steven
    Giles, Graham G.
    Gunter, Marc J.
    Harrison, Tabitha A.
    Hoffmeister, Michael
    Newcomb, Polly A.
    Ogino, Shuji
    Phipps, Amanda I.
    Qu, Conghui
    Schoen, Robert E.
    Pellatt, Andrew
    Woods, Michael O.
    Van Guelpen, Bethany
    Stevens, Patrick
    Hampel, Heather
    Peters, Ulrike
    McElroy, Joseph P.
    Toland, Amanda E.
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [8] Current therapy of KRAS-mutant lung cancer
    Aron Ghimessy
    Peter Radeczky
    Viktoria Laszlo
    Balazs Hegedus
    Ferenc Renyi-Vamos
    Janos Fillinger
    Walter Klepetko
    Christian Lang
    Balazs Dome
    Zsolt Megyesfalvi
    [J]. Cancer and Metastasis Reviews, 2020, 39 : 1159 - 1177
  • [9] Integrative Analysis of Next-Generation Sequencing for Next-Generation Cancer Research toward Artificial Intelligence
    Park, Youngjun
    Heider, Dominik
    Hauschild, Anne-Christin
    [J]. CANCERS, 2021, 13 (13)
  • [10] DUAL CHECKPOINT ABROGATION IS SYNERGISTIC IN KRAS-MUTANT CANCER
    不详
    [J]. CANCER DISCOVERY, 2015, 5 (09) : 903 - 903
12345